Candriam S.C.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001537014

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeTechnology TiltHigh Turnover how tags are computed

Q4 2025 · 665 positions · Total reported value $19.83B · Top-10 concentration 32.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.4% · 21 new · 252 cut · 51 exited

Active Share (vs S&P 500): 37.1% · vs QQQ: 52.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.6% · vs SPY -2.8% · Prev Value $22.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $22.25B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Candriam S.C.A. disclosed 665 equity positions with a combined reported value of $19.83B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 32.8% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were NVDA ($1.26B), MSFT ($1.25B), AAPL ($911.76M). By sector, the heaviest allocations are Technology 39.8%, Health Care 23.1%. Versus the prior quarter, allocation shifted toward Health Care (+3.2pp) and away from Communication Services (-1.0pp), Technology (-2.1pp).

Versus the prior quarter, Candriam S.C.A. opened 21 new positions, trimmed 252 and fully exited 51, a turnover rate of 47.4% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q4 2025 were BABA ($40.47M), SOLS ($19.16M), IMVT ($17.30M).

Of the 51 positions fully exited versus the prior quarter, the largest were OLED ($27.15M), MTLS ($23.16M), KMX ($22.17M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • BABA ALIBABA GROUP HLDG LTD · $40.47M
  • SOLS SOLSTICE ADVANCED MATLS INC · $19.16M
  • IMVT IMMUNOVANT INC · $17.30M
  • STOK STOKE THERAPEUTICS INC · $14.18M
  • TMDX TRANSMEDICS GROUP INC · $13.28M
  • MNMD MIND MEDICINE MINDMED INC · $13.01M
  • EYPT EYEPOINT INC · $12.32M
  • HST HOST HOTELS & RESORTS INC · $10.38M

Fully Exited (vs previous quarter)

  • OLED UNIVERSAL DISPLAY CORP · prev qtr: $27.15M
  • MTLS MATERIALISE NV · prev qtr: $23.16M
  • KMX CARMAX INC · prev qtr: $22.17M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $21.26M
  • HIMS HIMS & HERS HEALTH INC · prev qtr: $17.37M
  • ACAD ACADIA PHARMACEUTICALS INC · prev qtr: $11.47M
  • LRN STRIDE INC · prev qtr: $10.96M
  • PTCT PTC THERAPEUTICS INC · prev qtr: $8.98M

Insider Transactions (Form 4)

Latest Candriam S.C.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Candriam S.C.A. is a Luxembourg-based asset management firm founded in 1989, now part of New York Life Investments, with headquarters in Strassen, Luxembourg. The firm employs a responsible investment approach integrating ESG factors across various asset classes.

Investment Approach

Responsible investment with ESG integration, combining quantitative and fundamental research, offering both active and passive investment strategies

Asset Classes

Equities, fixed income, alternatives, multi-asset solutions

Notable Facts

Part of New York Life Investments, strong focus on sustainable investing, acquired in 2018

AUM

$154.7B (SEC Form ADV regulatory figure)

Official disclosures available through SEC filings

Sector Allocation

Technology 39.8%
Health Care 23.1%
Financials 9.0%
Utilities 2.2%
Other 4.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.76M $1.26B 6.36%
6.36%
Reduce
2 2.59M $1.25B 6.32%
6.32%
Reduce
3 3.35M $911.76M 4.60%
4.60%
Reduce
4 2.52M $789.51M 3.98%
3.98%
Add
5 2.51M $578.28M 2.92%
2.92%
Add
6 1.43M $496.11M 2.50%
2.50%
Hold
7 446.26K $479.61M 2.42%
2.42%
Reduce
8 804.65K $252.51M 1.27%
1.27%
Reduce
9 1.08M $246.24M 1.24%
1.24%
Add
10 417.07K $238.11M 1.20%
1.20%
Reduce
11 763.80K $232.12M 1.17%
1.17%
Reduce
12 1.83M $224.89M 1.13%
1.13%
Add
13 616.58K $216.25M 1.09%
1.09%
Add
14 622.69K $200.65M 1.01%
1.01%
Reduce
15 1.07M $197.70M 1.00%
1.00%
Add
16 1.04M $178.46M 0.90%
0.90%
Reduce
17 297.72K $172.52M 0.87%
0.87%
Add
18 205.29K $168.41M 0.85%
0.85%
Add
19 249.92K $164.98M 0.83%
0.83%
Reduce
20 291.04K $164.84M 0.83%
0.83%
Add
21 615.59K $163.08M 0.82%
0.82%
Reduce
22 205.33K $158.50M 0.80%
0.80%
Add
23 749.60K $155.14M 0.78%
0.78%
Add
24 528.84K $150.94M 0.76%
0.76%
Reduce
25 1.28M $134.28M 0.68%
0.68%
Reduce
26 857.54K $131.37M 0.66%
0.66%
Add
27 391.74K $128.22M 0.65%
0.65%
Reduce
28 1.02M $127.65M 0.64%
0.64%
Reduce
29 913.08K $124.25M 0.63%
0.63%
Add
30 262.79K $118.19M 0.60%
0.60%
Reduce
31 1.13M $107.73M 0.54%
0.54%
Reduce
32 469.77K $107.54M 0.54%
0.54%
Add
33 478.97K $105.24M 0.53%
0.53%
Reduce
34 761.42K $103.69M 0.52%
0.52%
Add
35 19.31K $103.42M 0.52%
0.52%
Add
36 481.07K $103.03M 0.52%
0.52%
Hold
37 277.05K $102.50M 0.52%
0.52%
Add
38 225.29K $102.14M 0.52%
0.52%
Add
39 447.32K $100.83M 0.51%
0.51%
Add
40 292.91K $100.79M 0.51%
0.51%
Reduce
41 185.71K $97.05M 0.49%
0.49%
Add
42 669.51K $95.95M 0.48%
0.48%
Reduce
43 447.02K $95.42M 0.48%
0.48%
Reduce
44 5.70M $95.35M 0.48%
0.48%
Add
45 1.19M $95.20M 0.48%
0.48%
Add
46 224.33K $89.21M 0.45%
0.45%
Add
47 94.45K $85.61M 0.43%
0.43%
Add
48 310.90K $84.32M 0.42%
0.42%
Add
49 507.86K $82.26M 0.41%
0.41%
Reduce
50 1.03M $82.12M 0.41%
0.41%
Add

FAQ

What did Candriam S.C.A. buy in 2025-Q4?

In its 2025-Q4 13F filing, Candriam S.C.A. reported 665 equity positions worth $19.83B in aggregate; its largest disclosed positions were NVDA ($1.26B), MSFT ($1.25B), AAPL ($911.76M).

How large is Candriam S.C.A.'s portfolio?

Candriam S.C.A. reported $19.83B of long equity holdings across 665 positions as of 2025-Q4. Top-10 holdings account for 32.8% of reported value.

What is Candriam S.C.A.'s investment style?

HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/candriam-s-c-a/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →